Drug
Etidronate
Etidronate is a pharmaceutical drug with 5 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
100%(2 trials)
Phase Distribution
Ph phase_3
1
20%
Ph not_applicable
1
20%
Ph phase_2
2
40%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(2)
Detailed Status
Completed2
Recruiting2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)
Trials by Status
active_not_recruiting120%
completed240%
recruiting240%
Recent Activity
3 active trials
Showing 5 of 5
recruitingphase_2
Treatment of Ectopic Calcification in Fahr's Disease or Syndrome
NCT05662111
active_not_recruitingnot_applicable
Effect of Different Irrigation Protocols on Postoperative Endodontic Pain and Inflammation
NCT07116252
recruitingphase_3
The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum
NCT05832580
completedphase_2
Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC)
NCT01585402
completed
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
NCT01077817
Clinical Trials (5)
Showing 5 of 5 trials
NCT05662111Phase 2
Treatment of Ectopic Calcification in Fahr's Disease or Syndrome
NCT07116252Not Applicable
Effect of Different Irrigation Protocols on Postoperative Endodontic Pain and Inflammation
NCT05832580Phase 3
The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum
NCT01585402Phase 2
Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC)
NCT01077817
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5